Trial Profile
A 12-week, randomized, double-blind, multi-center, vehicle-controlled, parallel group study to assess the efficacy and safety of the diclofenac sodium gel 1% for the relief of signs and symptoms in patients with osteoarthritis of the knee
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jan 2008
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Novartis
- 17 Dec 2007 Status changed from in progress to completed.
- 22 May 2007 The expected completion date for this trial is now 1 Jun 2007.
- 19 Feb 2007 New trial record.